Saniona AB:s valbere
Saniona AB:s valberedning inför årsstämman 2023
November 25, 2022 09:30 ET | Saniona AB
PRESSMEDDELANDE 25 november 2022 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling, tillkännager idag valberedningens sammansättning inför årsstämman 2023 Enligt...
Saniona AB’s Nominat
Saniona AB’s Nomination Committee for the Annual General Meeting 2023
November 25, 2022 09:30 ET | Saniona AB
PRESS RELEASE November 25, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced the composition of the Nomination Committee for the Annual General Meeting 2023. ...
Elispot and Fluorospot Market
ELISpot and FluoroSpot Assay Market Report 2022: Increasing Vaccine Development to Address Challenges of Antimicrobial Resistance Drives Growth
November 21, 2022 08:38 ET | Research and Markets
Dublin, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The "ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplants, Vaccine...
GMILogo_Vertical-Gradient.png
Neurovascular Devices Market to hit USD 4.5 billion by 2030, says Global Market Insights Inc.
November 21, 2022 06:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The neurovascular devices market size is set to reach USD 4.5 billion by 2030, according to a new research report by Global Market Insights...
Saniona publicerar s
Saniona publicerar sin delårsrapport för det tredje kvartalet 2022
November 17, 2022 02:00 ET | Saniona AB
  Q3 2022 (Q3 2021)Jan–sep 2022 (jan–sep 2021)Intäkter uppgick till 2,4 MSEK (2,3 M)Intäkter uppgick till 12,0 MSEK (7,6 M)Rörelseresultat uppgick till 21,8 MSEK (-88,2 M)Periodens resultat uppgick...
Saniona publishes it
Saniona publishes its interim report for the third quarter of 2022
November 17, 2022 02:00 ET | Saniona AB
  Three Months Ended September 30, 2022 (2021)Nine Months Ended September 30, 2022 (2021)Revenue was SEK 2.4 M (2.3 M)Revenue was SEK 12.0 M (7.6 M)Operating profit/loss was SEK 21.8 M (-88.2 M)Net...
mrf.jpg
CBD Gummies Market Worth USD 13.9 Billion by 2028 at 30.7% CAGR - Report by Market Research Future (MRFR)
November 16, 2022 09:30 ET | Market Research Future
New York, US, Nov. 16, 2022 (GLOBE NEWSWIRE) -- CBD Gummies Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), "CBD Gummies Market Information By...
Pure Extracts Logo.jpg
Pure Extracts Receives Approval from Manitoba Liquor & Lotteries to list Pure Pulls Vapes and Pure Chews Edibles
November 16, 2022 08:45 ET | Pure Extracts Technologies Corp.
VANCOUVER, British Columbia, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction...
Vantage Market Research.png
CBD Gummies Market Size & Share to Surpass $6.8 Billion by 2028 | Vantage Market Research
November 16, 2022 05:39 ET | Vantage Market Research
WASHINGTON, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Global CBD Gummies Market was valued at $1.4 Billion in 2021 and is projected to surpass a valuation of $6.8 Billion by 2028 at a CAGR of 30.2% during...
ReportLinker logo.jpg
The global ELISpot and FluoroSpot Assays market size is projected to reach USD 390 million by 2027 from USD 274 million in 2022, at a CAGR of 7.3%
November 10, 2022 07:49 ET | ReportLinker
New York, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "ELISpot and FluoroSpot Assay Market by Product, Application, End User - Global Forecast to 2027" -...